BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32532875)

  • 1. Case report for an adolescent with germline RET mutation and alveolar rhabdomyosarcoma.
    Crawford KA; Berlow NE; Tsay J; Lazich M; Mancini M; Noakes C; Huang T; Keller C
    Cold Spring Harb Mol Case Stud; 2020 Jun; 6(3):. PubMed ID: 32532875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional impact of a germline RET mutation in alveolar rhabdomyosarcoma.
    Berlow NE; Crawford KA; Bult CJ; Noakes C; Sloma I; Rudzinski ER; Keller C
    Cold Spring Harb Mol Case Stud; 2021 Jun; 7(3):. PubMed ID: 33722797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The clinical patterns and RET proto-oncogene in fifteen multiple endocrine neoplasia type 2A pedigrees].
    Zhou YL; Zhu SX; Li JJ; Liu JB; Yin M; Xiao BY; Yu CL; Wang LM; Gu LQ; Cui B; Ning G; Li XY; Zhao YJ
    Zhonghua Nei Ke Za Zhi; 2007 Jun; 46(6):466-70. PubMed ID: 17663821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.
    Zhou Y; Zhao Y; Cui B; Gu L; Zhu S; Li J; Liu J; Yin M; Zhao T; Yin Z; Yu C; Chen C; Wang L; Xiao B; Hong J; Zhang Y; Tang Z; Wang S; Li X; Ning G
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):570-6. PubMed ID: 17573899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of rapid and accurate screening test for RET hotspot somatic and germline mutations in MEN2 syndromes.
    Zupan A; Glavač D
    Exp Mol Pathol; 2015 Dec; 99(3):416-25. PubMed ID: 26321248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGFR4 signaling couples to Bim and not Bmf to discriminate subsets of alveolar rhabdomyosarcoma cells.
    Wachtel M; Rakic J; Okoniewski M; Bode P; Niggli F; Schäfer BW
    Int J Cancer; 2014 Oct; 135(7):1543-52. PubMed ID: 24550147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of Germline RET variants identified by targeted sequencing and associated Multiple Endocrine Neoplasia type 2 susceptibility in China.
    Qi XP; Zhao JQ; Fang XD; Lian BJ; Li F; Wang HH; Cao ZL; Zheng WH; Cao J; Chen Y
    BMC Cancer; 2021 Apr; 21(1):369. PubMed ID: 33827484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection of the PAX3-FOXO1 fusion gene in circulating tumor-derived DNA in a case of alveolar rhabdomyosarcoma.
    Eguchi-Ishimae M; Tezuka M; Kokeguchi T; Nagai K; Moritani K; Yonezawa S; Tauchi H; Tokuda K; Ishida Y; Ishii E; Eguchi M
    Genes Chromosomes Cancer; 2019 Aug; 58(8):521-529. PubMed ID: 30739374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAX3/7-FOXO1 fusion-negative alveolar rhabdomyosarcoma in Schuurs-Hoeijmakers syndrome.
    Ohkawa T; Nishimura A; Kosaki K; Aoki-Nogami Y; Tomizawa D; Kashimada K; Morio T; Kato M; Mizutani S; Takagi M
    J Hum Genet; 2022 Jan; 67(1):51-54. PubMed ID: 34341476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the role of RET polymorphisms/haplotypes as modifier loci for MEN 2, and analysis of the correlation with the type of RET mutation in a series of Spanish patients.
    Fernández RM; Navarro E; Antiñolo G; Ruiz-Ferrer M; Borrego S
    Int J Mol Med; 2006 Apr; 17(4):575-81. PubMed ID: 16525712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Homozygous RET K666N Genotype With an MEN2A Phenotype.
    Jaber T; Hyde SM; Cote GJ; Grubbs EG; Giles WH; Stevens CA; Dadu R
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1269-1272. PubMed ID: 29408964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes.
    Romei C; Mariotti S; Fugazzola L; Taccaliti A; Pacini F; Opocher G; Mian C; Castellano M; degli Uberti E; Ceccherini I; Cremonini N; Seregni E; Orlandi F; Ferolla P; Puxeddu E; Giorgino F; Colao A; Loli P; Bondi F; Cosci B; Bottici V; Cappai A; Pinna G; Persani L; Verga U; Boscaro M; Castagna MG; Cappelli C; Zatelli MC; Faggiano A; Francia G; Brandi ML; Falchetti A; Pinchera A; Elisei R;
    Eur J Endocrinol; 2010 Aug; 163(2):301-8. PubMed ID: 20516206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A NOVEL DOUBLE MUTATION VAL648ILE AND VAL804LEU OF RET PROTO-ONCOGENE IN MULTIPLE ENDOCRINE NEOPLASIA TYPE 2.
    Verrienti A; Carbone A; Bellitti P; Fabiano MC; De Rose RF; Maranghi M; Lucia P; Durante C; Rosignolo F; Pecce V; Sponziello M; Puppin C; Costante G; Bruno R
    Endocr Pract; 2015 Nov; 21(11):1248-54. PubMed ID: 26247112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 6-Base Pair in Frame Germline Deletion in Exon 7 Of RET Leads to Increased RET Phosphorylation, ERK Activation, and MEN2A.
    Latteyer S; Klein-Hitpass L; Khandanpour C; Zwanziger D; Poeppel TD; Schmid KW; Führer D; Moeller LC
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1016-22. PubMed ID: 26765577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double germline mutations in the RET Proto-oncogene in MEN 2A and MEN 2B kindreds.
    Dvorakova S; Vaclavikova E; Ryska A; Cap J; Vlcek P; Duskova J; Kodetova D; Holub V; Novak Z; Bendlova B
    Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):192-6. PubMed ID: 16705552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAX3-FOXO1 and FGFR4 in alveolar rhabdomyosarcoma.
    Marshall AD; van der Ent MA; Grosveld GC
    Mol Carcinog; 2012 Oct; 51(10):807-15. PubMed ID: 21882254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical spectrum of multiple endocrine neoplasia type 2a caused by the rare intracellular RET mutation S891A.
    Schulte KM; Machens A; Fugazzola L; McGregor A; Diaz-Cano S; Izatt L; Aylwin S; Talat N; Beck-Peccoz P; Dralle H
    J Clin Endocrinol Metab; 2010 Sep; 95(9):E92-7. PubMed ID: 20554711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.
    Krampitz GW; Norton JA
    Cancer; 2014 Jul; 120(13):1920-31. PubMed ID: 24699901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of two novel germline RET variants associated with medullary thyroid carcinoma.
    Silva AL; Carmo F; Moura MM; Domingues R; Espadinha C; Leite V; Cavaco B; Bugalho MJ
    Endocrine; 2015 Jun; 49(2):366-72. PubMed ID: 25725622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncommon association of germline mutations of RET proto-oncogene and CDKN2A gene.
    Foppiani L; Forzano F; Ceccherini I; Bruno W; Ghiorzo P; Caroli F; Quilici P; Bandelloni R; Arlandini A; Sartini G; Cabria M; Del Monte P
    Eur J Endocrinol; 2008 Mar; 158(3):417-22. PubMed ID: 18299477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.